Published in FDA Law Weekly, March 22nd, 2007
Developed by Gen-Probe and marketed by Chiron, a Novartis business, the Procleix Tigris System provides blood centers a fully automated platform for Nucleic Acid Testing (NAT), ensuring rapid delivery of virus-screened blood to hospitals and clinics nationwide. The high-throughput Procleix Tigris System allows blood centers to process 1,000 blood samples in under 14 hours, enabling high volume individual donor testing.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.